SMi Drug Discovery develops a benchtop single‑molecule imaging platform that integrates super‑resolu Sign up to read more
| Allotment | Filed | Share Class | Round Size | Round Type |
|---|---|---|---|---|
2026-07-24 | £52k |
| Shareholder | Share class | Shares | Holding |
|---|---|---|---|
| NORCLIFFE NOMINEES LIMITEDCORP | A1 SHARES | 4,553,727 | 48.1% |
| 8888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 88888888888888888888888888 | 8888888888 | 8888888 | 88888 |
| 888888888888888888 | 8888888888 | 888888 | 8888 |
| 8888888888888 | 88888888 | 888888 | 8888 |
| 8888888888888 | 88888888 | 888888 | 8888 |
15 more shareholders on file , sign up free to see.
Companies with the most similar business descriptions.
Capital raised per employee divides the equity SMI DRUG DISCOVERY LIMITED raised in the last six months by the headcount in its most recent filed accounts. It is a rough read on how capital-intensive the business is: a high figure means the company is raising a lot relative to the number of people it employs, which is typical of hardware, biotech and other research-heavy businesses. Headcount comes from annual accounts and so lags the funding date, often by a year or more.
A share class is a category of shares carrying its own rights over voting, dividends and what happens to the money if the company is sold or wound up. UK companies typically issue Ordinary shares to founders and employees, then create a new Preferred class at each funding round, giving investors priority on proceeds ahead of the Ordinary holders. SMI DRUG DISCOVERY LIMITED has 5 distinct classes on file at Companies House; the rights attached to each are reproduced below as filed.
(1)THE A1 SHARES SHALL CARRY THE RIGHT TO VOTE; (2) THE A1 SHARES HAVE THE RIGHT TO RECEIVE DIVIDENDS AS PER THE COMPANY'S ARTICLES; (3) THE A1 SHARES HAVE THE RIGHT TO PARTICIPATE IN A RETURN OF CAPITAL AS PER THE COMPANY'S ARTICLES; AND (4) THE A1 SHARES ARE NON-REDEEMABLE.
(1)THE A1 SHARES SHALL CARRY THE RIGHT TO VOTE; (2) THE A1 SHARES HAVE THE RIGHT TO RECEIVE DIVIDENDS AS PER THE COMPANY'S ARTICLES; (3) THE A1 SHARES HAVE THE RIGHT TO PARTICIPATE IN A RETURN OF CAPITAL AS PER THE COMPANY'S ARTICLES; AND (4) THE A1 SHARES ARE NON-REDEEMABLE.
(1) THE A2 SHARES SHALL CARRY THE RIGHT TO VOTE; (2) THE A2 SHARES HAVE THE RIGHT TO RECEIVE DIVIDENDS AS PER THE COMPANY ARTICLES; (3) THE A2 SHARES HAVE THE RIGHT TO PARTICIPATE IN A RETURN OF CAPITAL AS PER THE COMPANY'S ARTICLES; AND (4) THE A2 SHARES ARE NON-REDEEMABLE.
(1) THE B SHARES SHALL NOT CARRY THE RIGHT TO VOTE; (2) THE B SHARES HAVE THE RIGHT TO RECEIVE DIVIDENDS AS PER THE COMPANY ARTICLES; (3) THE B SHARES HAVE THE RIGHT TO PARTICIPATE IN A RETURN OF CAPITAL AS PER THE COMPANY'S ARTICLES; AND (4) THE B SHARES ARE NON-REDEEMABLE.
(1) THE C SHARES SHALL CARRY THE RIGHT TO VOTE; (2) THE C SHARES HAVE THE RIGHT TO RECEIVE DIVIDENDS AS PER THE COMPANY ARTICLES; (3) THE C SHARES HAVE THE RIGHT TO PARTICIPATE IN A RETURN OF CAPITAL AS PER THE COMPANY'S ARTICLES; AND (4) THE C SHARES ARE NON-REDEEMABLE.